EPANOVA in Crohn's Disease, Study 1 (EPIC-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00613197
Recruitment Status : Completed
First Posted : February 12, 2008
Last Update Posted : April 4, 2013
Information provided by:
Tillotts Pharma AG